Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Reda Rawi

Showing results (31-40 of 85) with videos related to

Pageof 9
Sort By:
Cell Reports|July 12, 2023
Improved HIV-1 neutralization breadth and potency of V2-apex antibodies by in silico designGraham T Holt, Jason Gorman, Siyu Wang, et al.
Iscience|November 18, 2020
Glycan Positioning Impacts HIV-1 Env Glycan-Shield Density, Function, and Recognition by AntibodiesQing Wei, Audra A Hargett, Barbora Knoppova, et al.
Nature Structural & Molecular Biology|November 7, 2022
Cryo-EM structures of prefusion SIV envelope trimerJason Gorman, Chunyan Wang, Rosemarie D Mason, et al.
Structure (London, England : 1993)|April 30, 2022
Structure of an influenza group 2-neutralizing antibody targeting the hemagglutinin stem supersiteCrystal Sao-Fong Cheung, Jason Gorman, Sarah F Andrews, et al.
Biorxiv : the Preprint Server for Biology|February 5, 2024
Rapid Emergence and Evolution of SARS-CoV-2 Variants in Advanced HIV InfectionSung Hee Ko, Pierce Radecki, Frida Belinky, et al.
Frontiers in Immunology|June 17, 2021
Sequence-Signature Optimization Enables Improved Identification of Human HV6-1-Derived Class Antibodies That Neutralize Diverse Influenza A VirusesGwo-Yu Chuang, Chen-Hsiang Shen, Crystal Sao-Fong Cheung, et al.
Nature Communications|August 22, 2024
Rapid intra-host diversification and evolution of SARS-CoV-2 in advanced HIV infectionSung Hee Ko, Pierce Radecki, Frida Belinky, et al.
Structure (London, England : 1993)|April 12, 2022
Structural basis for llama nanobody recognition and neutralization of HIV-1 at the CD4-binding siteTongqing Zhou, Lei Chen, Jason Gorman, et al.
Immunity|March 2, 2024
Protective human monoclonal antibodies target conserved sites of vulnerability on the underside of influenza virus neuraminidaseJulia Lederhofer, Yaroslav Tsybovsky, Lam Nguyen, et al.
Mabs|June 22, 2023
Improved pharmacokinetics of HIV-neutralizing VRC01-class antibodies achieved by reduction of net positive charge on variable domainYoung D Kwon, Amarendra Pegu, Eun Sung Yang, et al.
Pageof 9

Showing results (31-40 of 85) with videos related to

Sort By:
Pageof 9
Cell Reports|July 12, 2023
Improved HIV-1 neutralization breadth and potency of V2-apex antibodies by in silico designGraham T Holt, Jason Gorman, Siyu Wang, et al.
Iscience|November 18, 2020
Glycan Positioning Impacts HIV-1 Env Glycan-Shield Density, Function, and Recognition by AntibodiesQing Wei, Audra A Hargett, Barbora Knoppova, et al.
Nature Structural & Molecular Biology|November 7, 2022
Cryo-EM structures of prefusion SIV envelope trimerJason Gorman, Chunyan Wang, Rosemarie D Mason, et al.
Structure (London, England : 1993)|April 30, 2022
Structure of an influenza group 2-neutralizing antibody targeting the hemagglutinin stem supersiteCrystal Sao-Fong Cheung, Jason Gorman, Sarah F Andrews, et al.
Biorxiv : the Preprint Server for Biology|February 5, 2024
Rapid Emergence and Evolution of SARS-CoV-2 Variants in Advanced HIV InfectionSung Hee Ko, Pierce Radecki, Frida Belinky, et al.
Frontiers in Immunology|June 17, 2021
Sequence-Signature Optimization Enables Improved Identification of Human HV6-1-Derived Class Antibodies That Neutralize Diverse Influenza A VirusesGwo-Yu Chuang, Chen-Hsiang Shen, Crystal Sao-Fong Cheung, et al.
Nature Communications|August 22, 2024
Rapid intra-host diversification and evolution of SARS-CoV-2 in advanced HIV infectionSung Hee Ko, Pierce Radecki, Frida Belinky, et al.
Structure (London, England : 1993)|April 12, 2022
Structural basis for llama nanobody recognition and neutralization of HIV-1 at the CD4-binding siteTongqing Zhou, Lei Chen, Jason Gorman, et al.
Immunity|March 2, 2024
Protective human monoclonal antibodies target conserved sites of vulnerability on the underside of influenza virus neuraminidaseJulia Lederhofer, Yaroslav Tsybovsky, Lam Nguyen, et al.
Mabs|June 22, 2023
Improved pharmacokinetics of HIV-neutralizing VRC01-class antibodies achieved by reduction of net positive charge on variable domainYoung D Kwon, Amarendra Pegu, Eun Sung Yang, et al.
Pageof 9